DAX ®12.722,20+0,37%TecDAX ®3.056,99-0,01%S&P 5003.354,28+0,08%NASDAQ11.124,60-0,12%
finanztreff.de

DGAP-CMS: Fresenius Medical Care AG & Co. KGaA: Release of a capital market information

| Quelle: Dow Jones Newsw... | Lesedauer etwa 2 min. | Text vorlesen Stop Pause Fortsetzen


DGAP Post-admission Duties announcement: Fresenius Medical Care AG & Co.
KGaA / Fresenius Medical Care AG & Co. KGaA / Announcement pursuant to Art.
5 para. 1 lit. b), para. 3 of Regulation (EU) No 596/2014 and Art. 2 para. 3
of Delegated Regulation (EU) 2016/1052
Fresenius Medical Care AG & Co. KGaA: Release of a capital market
information

2019-11-11 / 09:44
Dissemination of a Post-admission Duties announcement transmitted by DGAP -
a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

- Share buy-back - 21st Interim Report

In the period from November 4, 2019 until and including November 8, 2019, a
total of 177,000 shares were repurchased within the framework of the share
buy-back programme of Fresenius Medical Care AG & Co. KGaA ('Fresenius
Medical Care') announced on June 14, 2019 pursuant to Art. 5 para. 1 lit. a)
of Regulation (EU) No 596/2014 and Art. 2 para. 1 of Delegated Regulation
(EU) 2016/1052.

The purchase was carried out exclusively by a credit institution
commissioned by Fresenius Medical Care via the XETRA trading platform on the
Frankfurt Stock Exchange:

*Day of repurchase * *Aggregated volume in *Weighted average
number of shares * share price*
*in EUR *
04.11.2019 36,000 66.5550
05.11.2019 36,000 67.7284
06.11.2019 35,000 67.7370
07.11.2019 35,000 68.6833
08.11.2019 35,000 68.6178

The total volume of shares repurchased within the framework of this share
buy-back in the period from June 17, 2019 until and including November 8,
2019 therefore amounts to 3,903,735 shares.

Detailed information on the transactions pursuant to Art. 2 para. 3 of
Delegated Regulation (EU) 2016/1052 is available on Fresenius Medical Care's
website at www.freseniusmedicalcare.com under section Investors.

Fresenius Medical Care AG & Co. KGaA
represented by Fresenius Medical Care Management AG
represented by its Management Board

Bad Homburg v.d.H., November 11, 2019

2019-11-11 The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Archive at www.dgap.de
Language: English
Company: Fresenius Medical Care AG & Co. KGaA
Else-Kröner-Straße 1
61352 Bad Homburg
Germany
Internet: www.freseniusmedicalcare.com

End of News DGAP News Service

909271 2019-11-11



(END) Dow Jones Newswires

November 11, 2019 03:44 ET ( 08:44 GMT)
Werbung

Das könnte Sie auch interessieren

News-Suche

Suchbegriff:

Aktuelle Videos

HSBC Trading TV

Werbung

Trading-Tipp

Börsen & Märkte

US-Marktüberblick

zur Mediathek
Werbung

Werbung
Diese Seite empfehlenschliessen
Interessant, oder?
Teilen Sie diese Seite auf Facebook oder Twitter
Wenn Sie auf die Teilen-Buttons klicken und sich bei den Betreibern einloggen, werden Daten an den jeweiligen Betreiber übermittelt. Bitte beachten Sie die Datenschutzerklärung.
Aktuelle Umfrageschliessen
Wie, glauben Sie, wird der DAX am Ende dieser Woche - KW 33 - stehen?
Jetzt abstimmen!
Alle Umfragen ansehen